The Healthcare Supply Chain Association (HSCA) and the Healthcare Industry Supply Chain Institute (HISCI) have released the results of an independent survey regarding industry adoption and integration of identification technologies used to track items in the healthcare supply chain. These include unique product identification and location codes such as Global Trade Item Numbers [GTINS] and Global Location Numbers [GLNs].
Hapa has acquired Gottscho Printing Systems in an effort to create a single source for inline, in-house printing solutions for the pharmaceutical, medical, personal care, food, and FMCG industries. Hapa provides late-stage printing customization technologies, while Gottscho provides flexographic technologies. Both are known for providing on-demand printing technologies.
ROC IT Solutions reports that a major pharmaceutical manufacturer has upgraded its implementation of ROC IT Solutions technology for track and trace in Turkey. The company's distribution center in Turkey first deployed ROC IT Solutions software in 2009 to meet the Turkish Ministry of Health (MoH) directive for item-level serialization and upgraded after its parent company began using a newer version of ROC IT solutions in the United States.
The Global Harmonization Task Force (GHTF) has released its proposal for a draft guidance on a Unique Device Identification (UDI) system that could be used around the world. The goal of the guidance is to provide a common global framework for identifying medical devices, which could facilitate recognizing recalled items and reporting specific devices involved in adverse events. Comments on the draft are welcomed through April 30.
In February 2011, the European Parliament adopted the “Falsified Medicines Directive.” The legislation is intended to protect EU citizens from falsified medicines, which are defined as products that “may contain ingredients in the wrong dosage or no active ingredients at all.” A distinction is made between “falsified medicines” and “counterfeit medicines,” which are defined as “medicines that do not comply with EU law on intellectual and industrial property rights, such as registered trademarks or patent rights.” According to a mem
We hear a lot these days about sunrise dates in the global GS1 System of product identification and related supply-chain standards. A sunrise date is a date in the future, agreed to and typically announced years in advance, at which point an industry or market sector is expected to be prepared to implement a specific technology.
Comments on FDA's proposed update to its Bar Code Labeling guidance regarding vaccines are in, and they all reflect the challenges inherent to any sort of change in drug product identification. Industry seems ready to move toward alternative technologies, but some end-users fear that multiple coding technologies coexisting in the supply chain could lead to chaos. Some urge FDA to standardize—even beyond vaccines—but will FDA's efforts be enough to transform healthcare practice?
In October, Joseph Ringwood, COO, Systech International, joined PMP News Editor Daphne Allen to discuss the global serialization landscape in a live Webcast. Earlier this year, Allen interviewed Ringwood along with Systech’s customers to prepare the white paper, “Establishing a State of Readiness: Mass Serialization as a Business Strategy.” Systech International has more than 150 lines serialized and is involved in 90% of all serialization deployments.